申请人:Merck, Sharp & Dohme, Ltd.
公开号:US05686463A1
公开(公告)日:1997-11-11
A class of novel oxadiazoles, substituted on one of the ring carbon atoms with a non-aromatic azacyclic or azabicyclic ring, and substituted on the other ring carbon atom with a substituent of low lipophilicity; are potent muscarinic agonists, and have good CNS penetrability. The compounds are therefore useful in the treatment of neurological and mental illnesses.
一类新型噁二唑醇类化合物,其中一个环上的碳原子被非芳香性氮杂环或氮杂双环取代,另一个环上的碳原子被低亲脂性取代基取代;这些化合物是有效的肌氨酸激动剂,并具有良好的中枢神经系统穿透性。因此,这些化合物在治疗神经和精神疾病方面具有用途。